...
首页> 外文期刊>BMC Nephrology >Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease
【24h】

Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease

机译:肾功能,钙调控和慢性肾病患者住院时间

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Chronic kidney disease is associated with disruption of the endocrine system that distorts the balance between calcitriol, calcium, phosphate and parathyroid hormone in the calcium regulation system. This can lead to calcification of the arterial tree and increased risk of cardiovascular disease and death. In this study we develop a health metric, based on biomarkers involved in the calcium regulation system, for use in identifying patients at high risk for future high-cost complications. Methods This study is a retrospective observational study involving a secondary analysis of data from the kidney disease registry of a regional managed care organization. Chronic kidney disease patients in the registry from November 2007 through November 2011 with a complete set of observations of estimated glomerular filtration rate, calcitriol, albumin, free calcium, phosphate, and parathyroid hormone were included in the study (n = 284). Weibull regression model was used to identify the most significant lab tests in predicting “waiting time to hospitalization”. A multivariate linear path model was then constructed to investigate direct and indirect effects of the biomarkers on this outcome. Results The results showed negative significant direct effects of phosphate and parathyroid hormone on “waiting time to hospitalization”. Base on this result, the risk of hospitalization increases 16.8% for each 0.55 mg/dl increase in phosphate level and 13.5% for each 0.467 increase in the natural logarithm of parathyroid hormone. Positive indirect effects of calcitriol surrogate (calcidiol), free calcium, albumin and estimated glomerular filtration rate were observed but were relatively small in magnitude. Conclusion Variables involved in the calcium regulation system should be included in future efforts to develop a quality of care index for Chronic Kidney disease patients.
机译:背景技术慢性肾病与内分泌系统的破坏有关,使钙调节系统中的钙质,钙,磷酸钙和甲状旁腺激素之间的平衡扭曲。这可能导致动脉树的钙化和心血管疾病和死亡的风险增加。在这项研究中,我们基于钙调节系统的生物标志物开发一种健康指标,用于识别高风险的患者以获得未来的高成本并发症。方法本研究是回顾性观察研究,涉及来自区域管理组织的肾病登记处的数据的二次分析。慢性肾病患者在2011年11月至2011年11月的注册表中,具有一整套估计肾小球过滤速率,钙质,白蛋白,游离钙,磷酸盐和甲状旁腺激素的一整套观察(n = 284)。 Weibull回归模型用于确定预测“住院时间”的最重要实验室测试。然后构建多变量线性路径模型以研究生物标志物对此结果的直接和间接影响。结果结果表明,磷酸盐和甲状旁腺激素对“等待住院时间”的负面显着直接影响。基于该结果,每次0.55mg / dL的住院风险增加了16.8%,每种磷酸盐水平增加13.5%,甲状旁腺激素的天然对数增加0.467。观察到钙二醇替代(钙化二醇),游离钙,白蛋白和估计的肾小球过滤速率的正间间接作用,但幅度相对较小。结论涉及钙调节系统的变量应包括在未来的努力中,为慢性肾病患者提供护理质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号